原发性血小板增多症和急性白血病。
Essential thrombocythemia and acute leukemia.
作者信息
Ferrari D, Ticozzelli G, De Vizzi M, Corigliano P, De Vizzi G
机构信息
Divisione di Medicina Interna, Ospedale C. Cantù, Abbiategrasso, Milano, Italia.
出版信息
Haematologica. 1993 Nov-Dec;78(6):401-2.
PMID:8175035
Abstract
A case of leukemic evolution from essential thrombocythemia (ET) is described. The patient developed acute myeloid leukemia (AML) six months after diagnosis while receiving hydroxyurea (HU). He died in four days in spite of treatment with low-dose cytarabine (ARA-C).
摘要
本文描述了一例从原发性血小板增多症（ET）演变为白血病的病例。该患者在诊断后六个月接受羟基脲（HU）治疗时发展为急性髓系白血病（AML）。尽管接受了小剂量阿糖胞苷（ARA-C）治疗，他仍在四天后死亡。
Zotero 插件